Crossmark

Attenuation of Hypertension and protection of vascular inflammation in hyperaldosteronism: GPER1 as potential therapeutic candidate when MR antagonist is less satisfying?

Crossref DOI link: https://doi.org/10.1007/s12020-024-04106-6

Published Online: 2024-11-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lai, Yulian

Tang, Ziwei https://orcid.org/0000-0002-7560-5528
Du, Zhipeng

Zeng, Qinglian

Xia, Yu

Chen, Shangbin

Li, Xun

Cheng, Qingfeng

Mei, Mei

He, Wenwen
Funding

Funding for this research was provided by:

Chongqing Medical University program of Youth Innovation of Future Science (W0187)

National Natural Science Youth Foundation of China (82000744)
License Information

Text and Data Mining valid from 2024-11-20

Version of Record valid from 2024-11-20
More Information

Article History

Received: 20 August 2024

Accepted: 7 November 2024

First Online: 20 November 2024

Compliance with ethical standards

:

: The authors declare no competing interests.

: All animal procedures were approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (2020-734).

Document is current

Any future updates will be listed below